RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -92.3% | 4,400 | -72.8% | 0.00% | -100.0% |
| Q2 2022 | $13,000 | -75.9% | 16,200 | +63.6% | 0.00% | -80.0% |
| Q1 2022 | $54,000 | -30.8% | 9,900 | +22.2% | 0.01% | -16.7% |
| Q4 2021 | $78,000 | +136.4% | 8,100 | +326.3% | 0.01% | +200.0% |
| Q3 2021 | $33,000 | +94.1% | 1,900 | +171.4% | 0.00% | +100.0% |
| Q2 2021 | $17,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |